See more : NVE Corporation (NVEC) Income Statement Analysis – Financial Results
Complete financial analysis of Westlake Chemical Partners LP (WLKP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Westlake Chemical Partners LP, a leading company in the Chemicals industry within the Basic Materials sector.
- Amed Co., Ltd. (7575.TWO) Income Statement Analysis – Financial Results
- Uni Abex Alloy Products Limited (UNIABEXAL.BO) Income Statement Analysis – Financial Results
- UPC Technology Corporation (1313.TW) Income Statement Analysis – Financial Results
- Sasol Limited (SSL) Income Statement Analysis – Financial Results
- Prada S.p.A. (PRDSF) Income Statement Analysis – Financial Results
Westlake Chemical Partners LP (WLKP)
About Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B | 1.29B | 1.17B | 986.74M | 1.01B | 1.75B | 2.13B | 2.25B | 2.25B |
Cost of Revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M | 908.46M | 769.31M | 595.41M | 624.34M | 1.00B | 1.26B | 1.61B | 1.84B |
Gross Profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M | 377.16M | 403.67M | 391.33M | 382.88M | 745.81M | 872.61M | 635.65M | 409.10M |
Gross Profit Ratio | 32.54% | 23.69% | 36.36% | 39.19% | 34.75% | 29.34% | 34.41% | 39.66% | 38.01% | 42.63% | 41.01% | 28.26% | 18.17% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 27.09M | 26.62M | 28.58M | 22.16M | 26.95M | 24.62M | 27.26M | 21.97M | 20.68M | 21.30M | 24.05M | 22.49M | 0.00 |
Selling & Marketing | 2.67M | 3.06M | 2.44M | 3.73M | 2.33M | 2.97M | 2.00M | 2.92M | 2.87M | 7.95M | 1.40M | 1.62M | 0.00 |
SG&A | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
Other Expenses | 0.00 | 1.57M | 62.00K | 733.00K | 3.10M | 2.46M | 1.79M | 601.00K | 160.00K | 3.15M | 7.70M | 4.19M | 2.80M |
Operating Expenses | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
Cost & Expenses | 833.08M | 1.25B | 804.17M | 613.68M | 741.72M | 936.05M | 798.57M | 620.29M | 647.89M | 1.03B | 1.28B | 1.64B | 1.87B |
Interest Income | 0.00 | 13.41M | 8.82M | 12.04M | 19.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M | 21.43M | 21.86M | 12.61M | 4.97M | 10.50M | 8.03M | 8.94M | 8.95M |
Depreciation & Amortization | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M | 460.87M | 490.18M | 464.92M | 440.51M | 797.32M | 928.32M | 679.99M | 444.78M |
EBITDA Ratio | 39.65% | 29.52% | 42.77% | 47.26% | 42.18% | 35.85% | 41.79% | 47.15% | 43.75% | 45.57% | 43.63% | 30.23% | 19.76% |
Operating Income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M | 349.57M | 374.41M | 366.44M | 359.33M | 716.56M | 847.16M | 611.55M | 384.79M |
Operating Income Ratio | 30.04% | 21.82% | 33.81% | 36.52% | 32.07% | 27.19% | 31.92% | 37.14% | 35.68% | 40.95% | 39.81% | 27.19% | 17.09% |
Total Other Income/Expenses | -22.27M | -11.84M | -8.75M | -11.31M | -16.53M | -18.98M | -20.07M | -12.01M | -4.81M | -7.35M | -331.00K | -4.75M | -6.14M |
Income Before Tax | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M | 330.59M | 354.34M | 354.44M | 354.53M | 709.21M | 846.83M | 606.80M | 378.64M |
Income Before Tax Ratio | 28.17% | 21.08% | 33.08% | 35.35% | 30.56% | 25.71% | 30.21% | 35.92% | 35.20% | 40.53% | 39.80% | 26.98% | 16.82% |
Income Tax Expense | 813.00K | 1.02M | 549.00K | 564.00K | 728.00K | 22.00K | 1.28M | 1.04M | 672.00K | 199.39M | 300.28M | 210.88M | 131.67M |
Net Income | 54.28M | 334.83M | 401.39M | 341.12M | 332.90M | 49.35M | 48.67M | 40.94M | 39.83M | 13.58M | 546.55M | 395.92M | 246.97M |
Net Income Ratio | 4.56% | 21.02% | 33.04% | 35.29% | 30.49% | 3.84% | 4.15% | 4.15% | 3.95% | 0.78% | 25.69% | 17.60% | 10.97% |
EPS | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.53 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
EPS Diluted | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.51 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
Weighted Avg Shares Out | 35.25M | 35.22M | 35.21M | 35.20M | 34.49M | 32.24M | 28.39M | 27.06M | 27.06M | 27.06M | 25.37M | 25.37M | 25.37M |
Weighted Avg Shares Out (Dil) | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.68M | 28.39M | 27.29M | 27.10M | 27.06M | 25.37M | 25.37M | 25.37M |
Westlake Chemical Partners Announces Fourth Quarter and Full Year Earnings for 2021 Conference Call
Westlake Chemical Partners Announces Fourth Quarter and Full Year Earnings for 2021 Conference Call
Westlake Chemical Partners LP Announces Fourth Quarter 2021 Distribution
Westlake Chemical Partners LP Announces Fourth Quarter 2021 Distribution
Westlake Chemical Partners LP Announces Third Quarter 2021 Results
Westlake Chemical Partners LP Announces Third Quarter 2021 Results
Westlake Chemical Partners LP Announces Third Quarter 2021 Distribution
Westlake Chemical Partners LP Announces Third Quarter 2021 Distribution
Westlake Chemical Partners Announce Third Quarter Earnings for 2021 Conference Call
Westlake Chemical Partners Announce Third Quarter Earnings for 2021 Conference Call
Source: https://incomestatements.info
Category: Stock Reports
How has Westlake Chemical Partners’ net income changed?
Third quarter 2024 net income attributable to the Partnership of $18.1 million increased by $3.7 million compared to second quarter 2024 net income of $14.4 million, primarily due to higher third-party ethylene sales volume with higher margin on these sales.